Medicare Enrolled
Dr. Matthew Budoff, M.D.
Cardiovascular Disease · Torrance, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Budoff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Budoff?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Budoff
Dr. Matthew Budoff is a cardiovascular disease specialist in Torrance, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Budoff performed 81,072 Medicare services across 3,144 unique beneficiaries.
Between the years covered by Open Payments, Dr. Budoff received a total of $3,755,898 from 60 pharmaceutical and/or device companies across 3406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Budoff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in CA
$3,755,898 industry payments
Medicare Practice Summary
Medicare Utilization ↗81,072
Medicare services
Top 0% in CA for cardiovascular disease
3,144
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,054 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
78,992 | $0 | $1 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
1,067 | $259 | $1,030 |
| CT scan of heart for calcium evaluation A CT scan of the heart used to evaluate calcium levels in the blood vessels. |
402 | $92 | $370 |
| CT heart vessel analysis for artery disease Analysis of CT scan data from heart blood vessels to assess the severity of heart artery disease, including interpretation and report. |
144 | $931 | $4,000 |
| CT scan for bone mineral density A CT scan used to measure calcium and other minerals in the bone. This procedure assesses bone mineral content. |
80 | $114 | $344 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
62 | $123 | $545 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
60 | $326 | $1,310 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
54 | $105 | $430 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
49 | $35 | $145 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
36 | $1 | $87 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $130 | $535 |
| CT scan of neck blood vessels with contrast A computed tomography scan that uses dye to visualize the blood vessels in the neck. This imaging test helps examine the structure and flow within the neck's vascular system. |
23 | $169 | $930 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $76 | $305 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
14 | $131 | $690 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
14 | $182 | $720 |
| CT scan of chest blood vessels with contrast A CT scan that uses contrast dye to create detailed images of the blood vessels in the chest. |
12 | $182 | $940 |
| CT scan of head/brain with contrast A CT scan of the head or brain using a contrast dye to create detailed images of the brain's structure. |
11 | $84 | $560 |
| CT scan of chest with and without contrast A computed tomography scan of the chest performed using both intravenous contrast dye and without it to provide detailed images of internal structures. |
11 | $171 | $810 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,755,898
Total received (2018-2024)
Avg $536,557/year across 7 years
Top 0% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
3,406
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,451,213 (91.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$295,679 (7.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,005 (0.2%)
Scientific / Research
Research funding and grants
$1,000 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$574,074
2023
$406,909
2022
$487,476
2021
$558,227
2020
$407,997
2019
$640,390
2018
$680,825
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$99,592
Lilly USA, LLC
$72,135
Lexicon Pharmaceuticals, Inc.
$52,169
Amgen Inc.
$50,232
Regeneron Healthcare Solutions, Inc.
$43,868
Esperion Therapeutics, Inc.
$42,984
Merck Sharp & Dohme LLC
$37,799
HEARTFLOW, INC.
$35,139
Janssen Pharmaceuticals, Inc
$29,926
Seqirus USA Inc
$26,991
Boehringer Ingelheim Pharmaceuticals, Inc.
$21,693
AstraZeneca Pharmaceuticals LP
$14,224
Novartis Pharmaceuticals Corporation
$10,420
Amarin Pharma Inc.
$8,167
Genentech, Inc.
$6,192
Cleerly, Inc.
$5,373
IDORSIA PHARMACEUTICALS US INC
$3,540
Canon Medical Informatics, Inc.
$3,000
Corcept Therapeutics
$2,545
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$2,539
Eli Lilly and Company
$1,800
FUKUDA DENSHI Co., Ltd.
$1,500
Elucid Bioimaging Inc
$1,200
United Imaging Healthcare North America LLC
$812
Bayer Healthcare Pharmaceuticals Inc.
$150
GE HEALTHCARE
$67
PFIZER INC.
$17
Top 3 companies account for 39.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$423,956
Novo Nordisk Inc
$412,630
Lilly USA, LLC
$387,187
Amarin Pharma Inc.
$350,987
Esperion Therapeutics, Inc.
$302,498
Amgen Inc.
$292,148
Janssen Pharmaceuticals, Inc
$277,127
Merck Sharp & Dohme LLC
$236,043
Regeneron Healthcare Solutions, Inc.
$212,995
SANOFI-AVENTIS U.S. LLC
$199,122
Boehringer Ingelheim Pharmaceuticals, Inc.
$184,119
PFIZER INC.
$115,891
Lexicon Pharmaceuticals, Inc.
$52,608
Merck Sharp & Dohme Corporation
$43,740
HEARTFLOW, INC.
$35,139
Novartis Pharmaceuticals Corporation
$31,412
HeartFlow, Inc.
$27,649
Seqirus USA Inc
$26,991
Eli Lilly and Company
$25,070
E.R. Squibb & Sons, L.L.C.
$19,072
FUKUDA DENSHI Co., Ltd.
$11,250
NOVARTIS PHARMACEUTICALS CORPORATION
$8,745
Kowa Pharmaceuticals America, Inc.
$6,583
Genentech, Inc.
$6,192
Renalytix AI, Inc.
$6,000
Novo Nordisk AS
$5,550
Abbott Laboratories
$5,458
Cleerly, Inc.
$5,373
Medicure Pharma Inc.
$5,000
Actelion Pharmaceuticals, Ltd
$4,361
Arineta, Inc
$4,355
Elucid
$4,083
IDORSIA PHARMACEUTICALS US INC
$3,540
PORTOLA PHARMACEUTICALS, INC.
$3,303
Canon Medical Informatics, Inc.
$3,000
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$2,748
Corcept Therapeutics
$2,545
GE Healthcare
$2,000
GE HEALTHCARE
$1,779
GE HealthCare
$1,600
Bayer Healthcare Pharmaceuticals Inc.
$1,336
Elucid Bioimaging Inc
$1,200
Boehringer Ingelheim International GmbH
$1,107
United Imaging Healthcare North America LLC
$812
Fukuda Denshi Co., Ltd.
$750
Astellas Pharma US Inc
$279
Regeneron Pharmaceuticals, Inc.
$151
Actelion Pharmaceuticals US, Inc.
$98
Cook Medical LLC
$41
Edwards Lifesciences Corporation
$39
Akcea Therapeutics, Inc.
$36
BIOTRONIK INC.
$33
Bayer HealthCare Pharmaceuticals Inc.
$27
Boston Scientific Corporation
$25
United Therapeutics Corporation
$23
Medtronic, Inc.
$20
Alnylam Pharmaceuticals Inc.
$20
Janssen Scientific Affairs, LLC
$19
BOSTON SCIENTIFIC CORPORATION
$16
Teleflex LLC
$12
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
ADVANCE · AMPLATZER Occluders · BEVYXXA · BREZTRI · BRILINTA · CAMZYOS · CHANTIX · COOK · Catheter - GuideLiner · Cleerly Ischemia · Cleerly Labs · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · ElucidVivo · FARXIGA · FFRct · GENERAL ATHERECTOMY · HMG-CoA reductase inhibitor · HeartWare HVAD · INVOKANA · Inpefa · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LEXISCAN · Levemir · Lexiscan · LifeVest · Livalo · MULTAQ · NEXLETOL · NEXLIZET · Next Generation CT Systems · ONPATTRO · Ozempic · PELACARSEN · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Parsabiv · QUVIVIQ · Quadra Assura CRT Defibrillator · RYBELSUS · Repatha · Rybelsus · STEGLATRO · SpotLight · TEGSEDI · TRADJENTA · TRULICITY · TYVASO · Tresiba · UPTRAVI · VERQUVO · VS-2000 · VYNDAQEL · Vascepa · Victoza · Vitrea V-Score · WATCHMAN · Wegovy · XARELTO · Xience Alpine cornary stent system · ZEPBOUND · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
596
Per 100K population
6.1
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - SOUTH BAY
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Budoff is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Budoff experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Budoff performed 78,992 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Budoff receive payments from pharmaceutical companies?
Yes. Dr. Budoff received a total of $3,755,898 from 60 companies across 3,406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Budoff's costs compare to other cardiologists in Torrance?
Dr. Budoff's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Budoff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Torrance
Browse cardiologists in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology